Pan-Asia United States PrEvention of Sudden Cardiac Death Catheter Ablation Trial (PAUSE-SCD): rationale and study design

Keyphrases

• United States 100%
• Catheter Ablation 100%
• Sudden Cardiac Death 100%
• Pan-Asia 100%
• Sudden Cardiac Death Prevention 100%
• ICD Implantation 80%
• Asia 60%
• Recurrent Ventricular Tachycardia 60%
• Non-ischemic 40%
• Standard Medical Therapy 40%
• ICD Therapy 40%
• Ventricular Tachycardia Ablation 40%
• Death Studies 40%
• Clinical Outcomes 20%
• Etiology 20%
• Ablation 20%
• Randomized Trial 20%
• Cardiomyopathy 20%
• Patients at Risk 20%
• Structural Heart Disease 20%
• Primary Therapy 20%
• Ablation Therapy 20%
• Cardiovascular Outcomes 20%
• Prospective Registry 20%
• Natural History 20%
• Multicenter Randomized Controlled Trial 20%
• Rehospitalization 20%
• Ablation Study 20%
• Ablation Outcomes 20%
• Monomorphic Ventricular Tachycardia 20%

Medicine and Dentistry

• Sudden Cardiac Death 100%
• Ablation 100%
• Ventricular Tachycardia 83%
• Cardiovascular System 33%
• Combination Therapy 33%
• Arm 16%
• Randomized Controlled Trial 16%
• Ablation Therapy 16%
• Heart Disease 16%
• Patient Registry 16%
• Monomorphic Ventricular Tachycardia 16%
• Myocardial Disease 16%

Biochemistry, Genetics and Molecular Biology

• Sudden Cardiac Death 100%
• Ventricular Tachycardia 100%
• Randomized Controlled Trial 16%
• Patient Registry 16%